According to a new report LAMEA Urology Laser Market, published by KBV Research, the LAMEA Urology Laser Market would witness market growth of 7.25% CAGR during the forecast period (2019-2025).
The Brazil market dominated the LAMEA Non-Muscle-Invasive Bladder Cancer (NMIBC) Market by Country in 2018, and would continue to be a dominant market till 2025. The Argentina market is experiencing a CAGR of 9.6% during (2019 - 2025). Additionally, The UAE market would witness a CAGR of 8.1% during (2019 - 2025).
The Holmium Laser System market dominated the Saudi Arabia Urology Laser Market by Laser Type in 2018, growing at a CAGR of 6.7 % during the forecast period. The Thulium laser system market is experiencing a CAGR of 7.9% during (2019 - 2025). The Diode Laser System market is estimated to grow at a CAGR of 7.95% during (2019 - 2025).
The Benign Prostatic Hyperplasia (BPH) market dominated the South Africa Urology Laser Market by Application in 2018, thereby, achieving a market value of $9.3 Million by 2025. The Urolithiasis market is poised to grow at a CAGR of 6.9% during (2019 - 2025). The Non-Muscle-Invasive Bladder Cancer (NMIBC) market is anticipated to witness a CAGR of 8.9% during (2019 - 2025).
Structural Insights: https://www.kbvresearch.com/lamea-urology-laser-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Olympus Corporation, Johnson and Johnson (Ethicon, Inc.), Stryker Corporation, Boston Scientific Corporation, Richard Wolf GmbH, Cook Medical, Inc. (Cook Group), Karl Storz SE & Co. KG, Lumenis Ltd. (XIO Group), Allengers Medical Systems Limited, and Becton, Dickinson and Company
By Laser Type
By Application
By Country
Companies Profiled
Unique Offerings from KBV Research
Global Market
North America Market
Europe Market
Asia Pacific Market
Unique Offerings 
